TipRanks
Go Ultimate55% OFF

Bioxcel Therapeutics (BX20) Balance Sheet

Bioxcel Therapeutics Balance Sheet

Bioxcel Therapeutics's total assets for Q2 2026 were $28.80M, a decrease of 15.36% from the previous quarter. DE:BX20 total liabilities were $144.26M for the fiscal quarter, a 3.36% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 44.92M$ 38.34M$ 73.70M$ 205.85M$ 239.44M
$ 140.38M$ 131.44M$ 130.21M$ 129.08M$ 17.77M
$ -95.46M$ -93.10M$ -56.51M$ 76.78M$ 221.67M

Currency in USD

Bioxcel Therapeutics Debt to Assets

0100M200M300M0 %120 %240 %360 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets